4503: Using Component Based Diagnostics and Effective Allergen Doses for Diagnosis and Subcutaneous Immunotherapy Treatment

March 1, 2021

Prescription of immunotherapy requires an understanding of cross-reactivity patterns, extract stability, and optimal dosing. The application of component based diagnostic testing may enhance prescribing patterns. In addition, math free guidelines assist with determining effective maintenance dose ranges and optimal extract stability for SCIT, but complicating factors such as volume limitations, glycerin concentration, and unit limits put in place by insurance may limit application of these guidelines. Lack of understanding or variation in relevant allergenic epitopes in some cases may lead to decreased efficacy of this therapy as well. This seminar will use case scenarios and simulated prescription writing to review allergic cross-reactivity patterns, allergen extract stability patterns, optimal dosage goals and ways in which component based diagnostics may enhance currently used methods.

Credit claiming for this activity will be available through December 31, 2021. Requests to claim credit on or after January 1, 2022 will be subject to an administrative fee

Target Audience

  • Physicians
  • Allergists/Immunologists
  • Nurses
  • Nurse Practitioners
  • Allied Health Professionals

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Summarize the math-free guidelines for allergen doses and glycerin concentrations
  • Discuss cross-reactivity patterns of pollens and the stability of different extracts when mixed together (pollens vs molds vs danders vs dust mites), and how component based diagnostics may be applied to determine relevant allergens
  • Discuss case scenarios and how one may formulate a patient's immunotherapy prescription


Available credit: 
  • 1.00 Attendance
    Attendance credit.
  • 1.00 CE
    CE credit.
  • 1.00 CME
    CME credit.
Course opens: 
Course expires: 
Event starts: 
03/01/2021 - 2:45pm
Event ends: 
03/01/2021 - 3:45pm

The American Academy of Allergy, Asthma and Immunology (AAAAI) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.


The American Academy of Allergy, Asthma & Immunology designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CE Designation Statement

The American Academy of Allergy, Asthma, & Immunology (AAAAI) is a Provider, approved by the California Board of Registered Nursing, Provider #10704, for up to1.50 Contact Hours.


Credit claiming for this activity will expire at 11:59 pm on June 30, 2021. Requests to claim credit on or after July1, 2021 will be subject to an administrative fee.


To verify your participation in educational activities, you may be asked to provide your name, contact information, and/or other descriptors. The AAAAI will not release this information to outside entities. It may be used internally to inform you of other AAAAI educational activities. If you wish to have your information excluded from this process, please contact us at cme@aaaai.org

Activity-related questions should be directed to cme@aaaai.org.

Available Credit

  • 1.00 Attendance
    Attendance credit.
  • 1.00 CE
    CE credit.
  • 1.00 CME
    CME credit.


Please login or register to take this course.

Required Hardware/software

One of the two latest versions of Google Chrome, Mozilla Firefox, or Safari.

Internet Explorer is no longer supported.